Omada Health (OMDA) EBITDA (2024 - 2026)

Omada Health has disclosed EBITDA across 3 years of filings, most recently posting -$3.0 million for Q1 2026.

• EBITDA for Q1 2026 came in at -$3.0 million, up 68.56% year-over-year; the trailing twelve-month figure through Mar 2026 was -$6.3 million (up 83.25% YoY), and the FY2025 annual result was -$12.8 million, up 72.89% from the prior year.
• EBITDA came in at -$3.0 million for Q1 2026 at Omada Health, down from $5.2 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $5.2 million in Q4 2025 to a low of -$10.7 million in Q2 2024.
• The 3-year median for EBITDA is -$6.8 million (2024), against an average of -$5.5 million.
• Peak annual rise in EBITDA reached 162.53% in 2025, while the deepest fall reached 50.33% in 2025.
• Omada Health's EBITDA stood at -$8.2 million in 2024, then soared by 162.53% to $5.2 million in 2025, then plunged by 157.57% to -$3.0 million in 2026.
• The last three EBITDA figures came in at -$3.0 million (Q1 2026), $5.2 million (Q4 2025), and -$3.2 million (Q3 2025), per Business Quant data.